Table 1. Biological and demographic characteristics of patients.
| Variables | Results |
|---|---|
| Age, years | 60.5 ± 7.3 |
| Men, n (%) | 153 (80.9) |
| BMI, kg/m 2 | 27.6 ± 4.3 |
| BMI ≥ 30 kg/m2, n (%) | 47 (24.9) |
| BMI ≥ 25 kg/m2, n (%) | 135 (71.4) |
| Smokers, n (%) | 126 (66.7) |
| Diabetes, n (%) | 54 (29.6) |
| Arterial hypertension, n (%) | 139 (73.5) |
| Dyslipidemia, n (%) | 170 (90.0) |
| Metabolic syndrome, n (%) | 101 (56.1) |
| Patients at “high-risk” of NAFLD†, n (%) | 104 (55,3) |
| Patients “at risk” of NAFLD‡, n (%) | 149 (79.6) |
| Alcohol consumption, g/d | 0 [0–15] |
| Excessive alcohol consumption, n (%) | 12 (6.5) |
| Glycosylated hemoglobin, % | 6.30 ± 0.97 |
| HDL cholesterol, mmol/L | 1.04 ± 0.26] |
| LDL cholesterol, mmol/L | 2.23 ± 0.91 |
| Total cholesterol, mmol/L | 3.72 ± 1.17 |
| Triglycerides, mmol/L | 1.49 ± 0.82 |
| Aspartate aminotransferase, IU/L | 28.3 ± 12.4 |
| Alanine aminotransferase, IU/L | 32.7 ± 26.2 |
| Gamma-glutamyl transferase, IU/L | 30 [22–50] |
| Alkaline phosphatase, IU/L | 71 [57–88] |
| Total bilirubin, μmol/L | 13.0 ± 6.8 |
| Albumin, g/L | 36.0 ± 2.8 |
| Platelets, G/L | 256 ± 72 |
| Creatinine, μmol/L | 83.9 ± 23.4 |
| C-reactive protein, mg/L | 1.3 [0.7–2.9] |
| Prothrombin index or Factor V, % | 95.8 ± 11.7 |
| CAP ≥ 275 dB/m, n (%) | 88 (47.0) |
Quantitative data are expressed as mean ± standard deviation (SD) or median [interquartiles; IQR].
†: Patients with at least one of the following conditions: elevated ALT, diabetes, triglycerides ≥ 1.7 mmol/L, BMI ≥ 30 kg/m2.
‡: Patients with at least one of the following conditions: elevated ALT, diabetes, triglycerides ≥ 1.7 mmol/L, BMI ≥ 25 kg/m2.
BMI, body mass index; CAP, controlled attenuation parameter; HDL, high-density lipoprotein; LDL, low-density lipoprotein.